7. In July 2015, the "Mitigating Sample Specific Interferences in Clinical Samples" video lecture was presented by the then Anteo VP of Scientific Affairs, Mr. Josh Soldo. Mr. Soldo mentioned that a partnership was soon to be announced in relation to this innovative solution where Anteo Technologies has the potential to pre-treat HUNDREDS OF MILLIONS of patient specimens worldwide, improve the quality of reported patient results, and decrease global healthcare costs.
Q. Does such a partnership exist, and if not, what has proved to be the reason for the apparent lack of progress on this application, given that a partnership was expected to be announced within weeks of the AACC lecture? Also, what steps are currently being undertaken to transform this "innovative solution" into a commercial reality?
I could have missed an update on this area of work, so happy to be pointed in the right direction. This is an area that I had great hopes for, but find the lack of progress a little disturbing.
ADO Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)